IL6 and congenital rubella syndrome: Murata et al. reported a 70-year-old man who had been treated with nivolumab and ipilimumab for lung cancer and was diagnosed with CRS due to systemic symptoms with inflammation and elevated IL-6 after SARS-CoV-2 infection [51].